10X GENOMICS, INC. (TXG): Price and Financial Metrics


Today's Latest Price: $124.28 USD

2.88 (2.37%)

Updated Sep 25 4:00pm

Add TXG to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 70 in Medical - Services

See all "A" rated Strong Buy stocks

TXG Daily Price Range
TXG 52-Week Price Range

TXG Stock Price Chart Technical Analysis Charts

TXG Price/Volume Stats

Current price $124.28 52-week high $125.92
Prev. close $121.40 52-week low $45.11
Day low $120.32 Volume 772,245
Day high $124.62 Avg. volume 684,989
50-day MA $107.11 Dividend yield N/A
200-day MA $85.35 Market Cap 12.47B

10X GENOMICS, INC. (TXG) Company Bio

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by Serge Saxonov, Ben Hindson, Kevin D. Ness and Eduard Diviu Terradas on July 2, 2012 and is headquartered in Pleasanton, CA.

TXG Latest News Stream

Event/Time News Detail
Loading, please wait...

TXG Latest Social Stream

Loading social stream, please wait...

View Full TXG Social Stream

Latest TXG News From Around the Web

Below are the latest news stories about 10x Genomics Inc that investors may wish to consider to help them evaluate TXG as an investment opportunity.

The Daily Biotech Pulse: Marinus Epilepsy Study Meets Goal, Novavax Reaches Vaccine Manufacturing Deal, Outset Medical's IPO

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) 10X Genomics Inc (NASDAQ: TXG ) Applied Molecular Transport Inc. (NASDAQ: AMTI ) Avenue Therapeutics Inc (NASDAQ: ATXI ) Avidity Biosciences Inc (NASDAQ: RNA ) BioLife Solutions Inc (NASDAQ: BLFS ) Denali Therapeutics Inc (NASDAQ: DNLI ) Guardant Health Inc (NASDAQ: GH ) Immunomedics, Inc. (NASDAQ: IMMU ) - announced a deal to be bought by Gilead Sciences, Inc. (NASDAQ: GILD ) for $21 billion Inspire Medical Systems Inc (NYSE: INSP ) Kintara Therapeutics Inc (NASDAQ: KTRA ) Kura Oncology Inc (NASDAQ: KURA ) Nurix Therapeutics Inc (NASDAQ: NRIX ) Pacific Biosciences of California Inc (NASDAQ: PACB ) (announced the appointment of Susan Kim as CFO, effective Sept. 28) Shockwave Medical Inc (NASDAQ: SWAV ) SI-Bone Inc (NASDAQ...

Benzinga | September 15, 2020

3 Med Info Stocks to Improve Portfolio Health Amid Coronavirus Woes

3 Med Info Stocks to Improve Portfolio Health Amid Coronavirus Woes

Yahoo | September 14, 2020

10x Genomics prices upsized stock offering at $110

10x Genomics (TXG) has priced upsized public offering of its 4M (from 3.5M) Class A common stock at $110.00/share, at a discounted price from Sept. 10 close of $113.51.Underwriters' over-allotment is an additional 600K shares.Closing date is September 15.10x Genomics has rebounded from March lows of around $51 to around...

Seeking Alpha | September 11, 2020

10x Genomics Announces Pricing of Upsized Public Offering

PLEASANTON, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (NASDAQ:TXG) (the "Company") today announced the pricing of an upsized …

Benzinga | September 10, 2020

10x Genomics launches equity offering

10x Genomics (TXG) has commenced an underwritten public offering of 3.5M shares and underwriters have an option to purchase up to 525k additional shares.Price and other terms are yet to be determined.Shares are down 2.1% AH....

Seeking Alpha | September 8, 2020

Read More 'TXG' Stories Here

TXG Price Returns

1-mo 12.68%
3-mo 44.09%
6-mo 97.90%
1-year 143.54%
3-year N/A
5-year N/A
YTD 62.99%
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.6951 seconds.